Aussie Drug Developer Cryptopharma Inhales $1.6 Million In First-Round Funds

Cryptopharma, a developer of novel steroid compounds for severe asthma and other respiratory diseases, said it has raised AUS 2 million ($1.6 million) in first-round venture financing.